McWilliam, SJ ORCID: 0000-0002-0509-7425, Antoine, DJ, Rosala-Hallas, A ORCID: 0000-0001-8012-9995, Jones, A, MacLean, C, Prayle, A, Smyth, AR, Flaherty, L, Shaw, VE, Greenhalf, W et al (show 2 more authors)
(2017)
THE PROTEKT STUDY - A PHASE IIA, RANDOMISED, CONTROLLED, OPEN-LABEL TRIAL OF ROSUVASTATIN FOR THE PREVENTION OF AMINOGLYCOSIDE-INDUCED KIDNEY TOXICITY IN CHILDREN WITH CYSTIC FIBROSIS.
In: 31st Annual North American Cystic Fibrosis Conference, 2017-11-2 - 2017-11-4, Indiana Convention Center, Indianapolis, Indiana.
Text
NACFC Abstract 230517.docx - Author Accepted Manuscript Download (16kB) |
Official URL: https://onlinelibrary.wiley.com/doi/abs/10.1002/pp...
Item Type: | Conference or Workshop Item (Unspecified) |
---|---|
Depositing User: | Symplectic Admin |
Date Deposited: | 04 Dec 2017 10:00 |
Last Modified: | 19 Jan 2023 06:52 |
DOI: | 10.1002/ppul.23840 |
Related URLs: | |
URI: | https://livrepository.liverpool.ac.uk/id/eprint/3010363 |
Dimensions
Altmetric
Share
CORE (COnnecting REpositories)